Erratum: Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor (Oncogene (2006) 25, (7381-7390) DOI: 10.1038/sj.onc.1209737);Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor

Oncogene

Volumn 25, Issue 56, 2006, Pages 7381-7390

  Winograd Katz, S E ^a,b   Levitzki, A ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cisplatin; EGPR; p38; Phosphorylation; Therapy

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ALANINE; ALKALINE PHOSPHATASE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTINEOPLASTIC AGENT; CISPLATIN; CYTARABINE; DIMETHYL SULFOXIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TEMOZOLOMIDE; THREONINE; UO 126; VINCRISTINE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 33748951221     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210160     Document Type: Erratum

References (37)

1. Bagowski CP, Stein-Gerlach M, Choidas A, Ullrich A. (1999). EMBO J 18: 5567-5576.
2. Bao J, Alroy I, Waterman H, Schejter ED, Brodie C, Gruenberg J et al. (2000). J Biol Chem 275: 26178-26186.
3. Bell M, Capone R, Pashtan I, Levitzki A, Engelberg D. (2001). J Biol Chem 276: 25351-25358.
4. Benhar M, Dalyot I, Engelberg D, Levitzki A. (2001). Mol Cell Biol 21: 6913-6926.
5. Benhar M, Engelberg D, Levitzki A. (2002). Oncogene 21: 8723-8731.
6. Countaway JL, McQuilkin P, Girones N, Davis RJ. (1990). J Biol Chem 265: 3407-3416.
7. Countaway JL, Northwood IC, Davis RJ. (1989). J Biol Chem 264: 10828-10835.
8. Cuevas BD, Lu Y, Mao M, Zhang J, LaPushin R, Siminovitch K et al. (2001). J Biol Chem 276: 27455-27461.
9. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. (2003). Oncogene 22: 5885-5896.
10. Deschesnes RG, Huot J, Valerie K, Landry J. (2001). Mol Biol Cell 12: 1569-1582.
11. Fan M, Chambers TC. (2001). Drug Resist Updat 4: 253-267.
12. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. (2003). Oncogene 22: 8983-8998.
13. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK et al. (1995). Cell 81: 727-736.
14. Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y et al. (2000). Cancer Res 60: 5988-5994.
15. Heisermann GJ, Gill GN. (1988). J Biol Chem 263: 13152-13158.
16. Heisermann GJ, Wiley HS, Walsh BJ, Ingraham HA, Fiol CJ, Gill GN. (1990). J Biol Chem 265: 12820-12827.
17. Hunter T, Ling N, Cooper JA. (1984). Nature 311: 480-483.
18. Kandel ES, Hay N. (1999). Exp Cell Res 253: 210-229.
19. Kartalou M, Essigmann JM. (2001). Mutat Res 478: 23-43.
20. Kaushal GP, Kaushal V, Hong X, Shah SV. (2001). Kidney Int 60: 1726-1736.
21. Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN et al. (1997). Genes Dev 11: 701-713.
22. Laemmli UK. (1970). Nature 227: 680-685.
23. Lin CR, Chen WS, Lazar CS, Carpenter CD, Gill GN, Evans RM et al. (1986). Cell 44: 839-848.
24. Litman P, Ohne O, Ben-Yaakov S, Yechezkel T, Salitra Y, Rubnov S et al. (2006). Submitted.
25. Morrison P, Takishima K, Rosner MR. (1993). J Biol Chem 268: 15536-15543.
26. Northwood IC, Gonzalez FA, Wartmann M, Raden DL, Davis RJ. (1991). J Biol Chem 266: 15266-15276.
27. Obenauer JC, Cantley LC, Yaffe MB. (2003). Nucleic Acids Res 31: 3635-3641.
28. Osherov N, Levitzki A. (1994). Eur J Biochem 225: 1047-1053.
29. Pandey P, Raingeaud J, Kaneki M, Weichselbaum R, Davis RJ, Kufe D et al. (1996). J Biol Chem 271: 23775-23779.
30. Schindler T, Sicheri F, Pico A, Gazit A, Levitzki A, Kuriyan J. (1999). Mol Cell 3: 639-648.
31. Siddik ZH. (2003). Oncogene 22: 7265-7279.
32. Takishima K, Friedman B, Fujiki H, Rosner MR. (1988). Biochem Biophys Res Commun 157: 740-746.
33. Takishima K, Griswold-Prenner I, Ingebritsen T, Rosner MR. (1991). Proc Natl Acad Sci USA 88: 2520-2524.
34. Vieira AV, Lamaze C, Schmid SL. (1996). Science 274: 2086-2089.
35. Viniegra JG, Losa JH, Sanchez-Arevalo VJ, Cobo CP, Soria VM, Ramon y Cajal S et al. (2002). Oncogene 21: 7131-7136.
36. West KA, Castillo SS, Dennis PA. (2002). Drug Resist Updat 5: 234-248.
37. Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, McNulty D et al. (1997). J Biol Chem 272: 12116-12121.